Haemopoietic Growth Factors, The Cell Cycle of Acute Myeloblastic Leukaemia Progenitors and Sensitivity to Cytosine Arabinoside

References

• Te Boekhorst P. A. W., Lowenberg B., Vlastuin M., Sonneveld P. Enhanced chemosensitivity of clonogenic blasts from patients with acute myeloid leukemia by G-CSF, IL-3 or GM-CSF stimulation. Leukemia 1993; 7, (8), 1191–1198
   Web of Science ®Google Scholar
• Aglietta M., Piacibello P., Pasquino P., Sanavio F., Stacchini A., Volta C., Monteverde A., Fubini L., Morelli S., Severino A. Rationale for the use of granulocyte-macrophage colony stimulating factor in oncology. Seminars in Oncology 1994; 21, (6), 5–9
   PubMed Web of Science ®Google Scholar
• Heil G., Chadid L., Hoezler D., Speipelt G., Mitrou P., Huber C., Kolbe K., Mertlesmann A. GM-CSF in a double-blind randomized, placebo controlled trial in therapy of adult patients with de novo acute myeloid leukemia (AML). Leukemia 1995; 9: 3–9
   PubMed Web of Science ®Google Scholar
• Yamada K., Furusawa S., Saito K., Waga K., Koike T., Al E. Concurrent use of granulocyte colony-stimulating factor with low-dose cytosine arabinoside and alarubicin for previously treated acute myelogenous leukemia: a pilot study. Leukemia 1995; 9: 10–14
   PubMed Web of Science ®Google Scholar
• Muhm M., Andreef M., Geissler K. rh GM-CSF in combination with chemotherapy-a new strategy in the therapy of acute myeloid leukemia. Blood 1989; 74, (Suppl. 1), 117a
   Google Scholar
• Bettelheim P., Valent P., Andreef M., Tafuri A., Haimi J., Gorischek C., Muhm M. Recombinant human granulocyte-macrophage colony stimulating factor in combination with standard induction chemotherapy in de novo acute myeloid leukemia. Blood 1991; 77: 700–711
   PubMed Web of Science ®Google Scholar
• Cannistra S., Di Carlo J., Groshek P., Kanakura Y., Berg D., Mayer R. J., Griffin J. D. Simultaneous administration of granulocyte-macrophage colony stimulating factor and cytosine arabinoside for the treatment of relapsed acute myeloid leukemia. Leukemia 1991; 5: 230–238
   PubMed Web of Science ®Google Scholar
• Estey E., Hall P., Kantarjian H., O'Brien S., Koller C. A., Beran M., Gutterman J., Deisseroth A., Keating M. Treatment of newly diagnosed acute myeloid leukemia with granulocyte-macrophage colony stimulating factor (GM-CSF) before and during continuous-infusion high-dose ara-c and daunorubicin: comparison to patients treated without GM-CSF. Blood 1992; 79: 2246–2255
   PubMed Web of Science ®Google Scholar
• Archimbaud E., Fenaux P., Reiffers J., Cordonnier C., Leblond V., Travade P., Troussard X. Granulocyte-macrophage-colony-stimulating factor in association to timedsequential chemotherapy with mitoxantrone, etoposide and cytarabine for refractory myelogenous leukemia. Leukemia 1993; 7, (3). 372–377
   Web of Science ®Google Scholar
• Puntous M., Lacombe F., Dumain P., Marit G., Cony-Makhoul P., Belloc F., Boiron J. M., Laurent G., Bernard P. H., Reiffers J. Treatment of relapsed acute myeloid leukemia using GM-CSF before intensive chemotherapy. Leukemia and Lymphoma 1993; 12: 95–102
   PubMed Web of Science ®Google Scholar
• Ohno R., Naoe T., Kanamura A., Yoshida M., Hiroaki A., Kobayashi I., Veda T. A double-blind controlled study of granulocyte colony-stimulating factor started two days before induction chemotherapy in refractory acute myeloid leukemia. Blood 1994; 83: 2086–2092
   PubMed Web of Science ®Google Scholar
• Delwel R., Dorssers L., Touw I., Wagemaker G., Lowenberg B. Human recombinant multilineage colony stimulating factor (interleukin 3) stimulator of acute myelocytic leukaemia progenitor cells in vitro. Blood 1987; 70: 333–338
   PubMed Web of Science ®Google Scholar
• Lowenberg B., Salem M., Delwel R. Effects of recombinant multi-CSF, GM-CSF, G-CSF and M-CSF on the proliferation and maturation of human AML in vitro. Blood Cells 1988; 14: 539
   PubMedGoogle Scholar
• Delwel R., Salem M., Pellens C., Dorssers L., Wagemaker G., Clark S. C., Lowenberg B. Growth regulation of human myeloid leukemia: Effects of five recombinant hematopoietic factors in a serum-free culture system. Blood 1988; 72: 1944–1949
   PubMed Web of Science ®Google Scholar
• Strife A., Lambek C., Wisniewski D., Gulati S., Gasson J. C., Golde D. W., Welte K., Gabrilove J. L., Clarkson B. Activities of four purified growth factors on highly enriched human haematopoietic progenitor cells. Blood 1987; 69: 1508–1523
   PubMed Web of Science ®Google Scholar
• Bot F. J., Eijk L. V., Schipper P., Lowenberg B. Effects of human interleukin-3 on granulocytic colony forming cells in human bone marrow. Blood 1989; 73: 115–1160
   Google Scholar
• Metcalf D. The colony stimulating factors:discovery, development and clinical applications. Cancer 1990; 65: 1285–1295
   Web of Science ®Google Scholar
• Smith M. A., Singer C. R. J., Pallister C. J., Smith J. G. The effect of haemopoietic growth factors on the cell cycle of AML progenitors and their sensitivity to cytosine arabinoside “in vitro”. British Journal of Haematology 1995; 90: 767–773
   PubMed Web of Science ®Google Scholar
• Smith M. A., Smith J. G., Provan A. B., Singer C. R. J. The effect of rh-cytokines on the sensitivity of normal human CFU-GM progenitors to Ara-C and on the S-phase activity of light density human bone marrow cells. Leukemia Research 1994; 18: 105–110
   PubMed Web of Science ®Google Scholar
• Pietsch T., Kyass U., Steffens U., Yakisan E., Hadam M. R., Ludwic W. D., Zsebo K., Wette C. Effects of stem cell factor (c-kit ligand) on proliferation of myeloid leukemia cells; heterogeneity in response and synergy with other hematopoietic growth factors. Blood 1992; 80: 1199–1206
   PubMed Web of Science ®Google Scholar
• Budel L. M., Delwel R., Buitenen C., Hoogerbrugge H., Lowenberg B. Effects of mast cell growth factor on acute myeloid leukemia cells in vitro: effects of combinations with other cytokines. Leukemia 1993; 7, (3), 426–434
   PubMed Web of Science ®Google Scholar
• Hoffman R., Tong J., Brandt J., Traycoff C., Bruno E., McGuire B. W., Gordon M. S., McNiece I., Srour E. F. The in vitro and in vivo effects of stem cell factor on human hematopoiesis. Stem Cells 1993; 11, (suppl. 2), 76–82
   Web of Science ®Google Scholar
• Mc Niece I. K., Zsebo K. M. The role of stem cell factor in the haematopoietic system. Cancer Investigation 1993; 11, (b), 724–729
   Web of Science ®Google Scholar
• Simmons P. J., Aylett G. W., Nivtta S., To L. B., Juttner C. A., Ashman K. L. c-kit is expressed by primitive human hematopoietic cells that give rise to colony forming cells in stroma-dependent or cytokine-supplemented culture. Experimental Hematology 1994; 22: 157–165
   PubMed Web of Science ®Google Scholar
• Bhalla K., Birkhofer M., Arlin Z., Grant S., Lutzky J., Graham G. Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human marrow cells. Leukemia 1988; 2, (12), 810–813
   Web of Science ®Google Scholar
• Gibson F. M., Scopes J., Daly S., Ball S. E., Gordon-Smith E. C. In vitro response of normal and aplastic anaemia bone marrow to mast cell growth factor and in combination with granulocyte-macrophage colony-stimulating factor and interleukin-3. Experimental Haematology 1994; 22, (3), 302–312
   PubMed Web of Science ®Google Scholar
• Carlesso N., Pregno P., Bresso P., Gallo E., Pileri A., Zsebo K., Ferrero D. Human recombinant stem cell factor stimulates in vitro proliferation of acute myeloid leukemia cells and expands the clonogenic pool. Leukemia 1992; 6, (7), 642–648
   Web of Science ®Google Scholar
• Brandt J., Briddell R. A., Srour E. F., Leemhuis T. B., Hoffman R. Role of c-kit ligand in expansion of human haemopoietic progenitor cells. Blood 1992; 79, (3), 634–641
   Web of Science ®Google Scholar
• Hoang T., Nara N., Wang G., Clark S., Minden M. D., McCulloch E. A. Effects of recombinant GM-CSF on the blast cells of acute myeloblastic leukemia. Blood 1986; 68: 313–316
   PubMed Web of Science ®Google Scholar
• Mc Culloch E. A., Kelleher C. A., Mijuadi J., Wang G., Cheng G. Y. C., Minden M. D., Curtis J. E. Heterogeneity in acute myeloblastic leukemia. Leukemia 1988; 2, (suppl. 12), 38s-39s
   Google Scholar
• Ferrero D., Carlesso N., Pregno P., Gallo E., Pileri A. Self renewal inhibition of acute myeloid leukemia clonogenic cells by biological inducers of differentiation. Leukemia 1992; 6: 100–106
   PubMed Web of Science ®Google Scholar
• Capizi R. L., Yang J. L., Cheng T., Bjornsson T., Sahasrabudhe D., Tan R. S., Chen Y. C. Alteration of the pharmacokinetics of high dose ara C by its metabolite, high ara U in patients with acute leukemia. Journal of Clinical Oncology 1983; 1: 763–771
   PubMed Web of Science ®Google Scholar
• Plunkett W., Lilie Mark J. O., Estey E., Keating M. J. Saturation of ara CTP accumulation during high-dose ara C therapy: pharmacologic rationale for intermediate-dose ara C. Seminars in Oncology 1987; 14: 159–166
   PubMed Web of Science ®Google Scholar
• White J. C., Rathmell J. P., Cappizzi R. L. Membrane transport influences the rate of accumulation of cytosine arabinoside in human leukemia cells. Journal of Clinical Investigation 1987; 79: 380–387
   PubMed Web of Science ®Google Scholar
• Rathmell J. P., Capizzi R. L., Craig J. (1978) Membrane phospholipid as a possible target for ara-C in human leukemia. Proceedings of the American Society for Clinical Oncology 1986; 5:47. 1986
   Google Scholar
• Bhalla K., Tourkina E., Huang Y., Tang C., Mahoney M. E., Ibrado A. M. Effect of hemopoietic growth factors G-CSF and pIXY 321 on the activity of high dose ARA-C in human myeloid leukemia cells. Leukemia and Lymphoma 1993; 10, (suppl.). 123–131
   PubMedGoogle Scholar